SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1726Merrill: Aloxi in PONV positive, but small opportunity Two phase 3 trials of Altom pope-12/14/2006
1725MGI PHARMA and HELSINN Announce Positive Phase 3 Results for Aloxi(R) (PalonosetIcebrg-12/14/2006
1724Dacogen(TM) (Decitabine) for Injection Data Presented at the American Society ofIcebrg-12/11/2006
1723Generic Zofran now out: investorshub.com Interestingly, Aloxi did OK recently,tuck-11/27/2006
1722MGI Pharma downgraded to "hold" Tuesday, November 07, 2006 6:40:34 AMIcebrg-11/7/2006
1721>>MGI PHARMA Announces Specific J Code Assignment for Dacogen(TM) Tuesday tuck-10/31/2006
1720>>10-26-06 0829ET DJ MGI Pharma Begins Organizational Restructuring >Mtuck-10/26/2006
1719I have seen the report, and what he says is reasonable, but . . . if AMTectuck-10/25/2006
1718MGI Pharma initiated with "buy" Tuesday, October 24, 2006 11:52:09 AMIcebrg-10/25/2006
1717MGI Pharma downgraded to "sell" Tuesday, October 24, 2006 6:42:47 AM Icebrg-10/24/2006
1716OTOH, JSA's record on their MOGN calls doesn't look too good: messages.tuck-10/24/2006
1715Jeff Slocum & Associates, a boutique St. Paul research firm, today downgradetuck-10/23/2006
1714Leerink upgraded this morning, and MOGN beat by 5 cents, showing a 2 cent profittuck-10/18/2006
1713ML this morning: MGI Pharma: Market Overly Negative on Generic Zofran Impact; KWard Knutson-10/17/2006
1712MGI Pharma "market perform," target price reduced Monday, October 16,Icebrg-10/17/2006
1711<<Ward, I agree with your analysis, but the strong Dacogen launch has beenWard Knutson-10/13/2006
1710Well, that's the lowest number I've seen for peak sales. Not that I'tuck-10/13/2006
1709MGI Pharma "neutral" Friday, October 13, 2006 5:34:54 AM ET Robert W.Icebrg-10/13/2006
1708Merrill seems to think it's a non-event: Saforis Approvable, Addt’l Phase Itom pope-10/13/2006
1707I think the market is now focused on strong Dacogen uptake, and looking at fairlWard Knutson-10/13/2006
1706>>MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powdertuck-10/12/2006
1705MGI Pharma Shares Up on Sales, Study Data © 2006 The Associated Press NEWIcebrg-9/27/2006
1704Glad to see that Merril is bullish on someone-g-eomzeta1961-9/26/2006
1703ML - Buy Dacogen Strong; Aquavan Data Positive; Raising Est. MGI Pharma raised tom pope-9/26/2006
1702Jon, my ARNA is still underwater at this point..bought too soon upon my coming bzeta1961-8/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News